Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Watkin

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Journal of Psychiatric Research|December 14, 2004
Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studiesStephen K Brannan, Craig H Mallinckrodt, Michael J Detke, et al.
Case Reports in Medicine|January 2, 2014
Multifocal and multicentric glioblastoma with leptomeningeal gliomatosis: a case report and review of the literatureSophia F Shakur, Esther Bit-Ivan, William G Watkin, et al.
BMC Psychiatry|August 30, 2007
Duloxetine in the treatment of major depressive disorder: an open-label studyJames I Hudson, David G Perahia, Inmaculada Gilaberte, et al.
Psychopharmacology|August 4, 2004
Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjectsStephan Chalon, Alvaro Pereira, Eric Lainey, et al.
Journal of Clinical Psychopharmacology|November 12, 2005
An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approachesMadelaine M Wohlreich, James M Martinez, Craig H Mallinckrodt, et al.
Statistics in Medicine|October 12, 2005
Comparing onset of antidepressant action using a repeated measures approach and a traditional assessment scheduleCraig H Mallinckrodt, Michael J Detke, Christopher J Kaiser, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|May 25, 2004
Duloxetine: A New Treatment for the Emotional and Physical Symptoms of DepressionCraig H. Mallinckrodt, David J. Goldstein, Michael J. Detke, et al.
Laboratory Medicine|April 29, 2015
Encrusted Cystitis Secondary to Corynebacterium glucuronolyticum in a 57-Year-Old Man Without Predisposing FactorsChelsea R Curry, Karan Saluja, Sanchita Das, et al.
The Journal of Clinical Psychiatry|October 5, 2006
Duloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy in U.S. Hispanic and majority Caucasian patientsRoberto Lewis-Fernández, Carlos Blanco, Craig H Mallinckrodt, et al.
Human Psychopharmacology|May 25, 2005
Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trialsJames I Hudson, Madelaine M Wohlreich, Daniel K Kajdasz, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Journal of Psychiatric Research|December 14, 2004
Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studiesStephen K Brannan, Craig H Mallinckrodt, Michael J Detke, et al.
Case Reports in Medicine|January 2, 2014
Multifocal and multicentric glioblastoma with leptomeningeal gliomatosis: a case report and review of the literatureSophia F Shakur, Esther Bit-Ivan, William G Watkin, et al.
BMC Psychiatry|August 30, 2007
Duloxetine in the treatment of major depressive disorder: an open-label studyJames I Hudson, David G Perahia, Inmaculada Gilaberte, et al.
Psychopharmacology|August 4, 2004
Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjectsStephan Chalon, Alvaro Pereira, Eric Lainey, et al.
Journal of Clinical Psychopharmacology|November 12, 2005
An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approachesMadelaine M Wohlreich, James M Martinez, Craig H Mallinckrodt, et al.
Statistics in Medicine|October 12, 2005
Comparing onset of antidepressant action using a repeated measures approach and a traditional assessment scheduleCraig H Mallinckrodt, Michael J Detke, Christopher J Kaiser, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|May 25, 2004
Duloxetine: A New Treatment for the Emotional and Physical Symptoms of DepressionCraig H. Mallinckrodt, David J. Goldstein, Michael J. Detke, et al.
Laboratory Medicine|April 29, 2015
Encrusted Cystitis Secondary to Corynebacterium glucuronolyticum in a 57-Year-Old Man Without Predisposing FactorsChelsea R Curry, Karan Saluja, Sanchita Das, et al.
The Journal of Clinical Psychiatry|October 5, 2006
Duloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy in U.S. Hispanic and majority Caucasian patientsRoberto Lewis-Fernández, Carlos Blanco, Craig H Mallinckrodt, et al.
Human Psychopharmacology|May 25, 2005
Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trialsJames I Hudson, Madelaine M Wohlreich, Daniel K Kajdasz, et al.
Pageof 5